{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T03:36:12Z","timestamp":1785814572527,"version":"3.56.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.diabres.2017.08.009","type":"journal-article","created":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T09:31:30Z","timestamp":1503567090000},"page":"21-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Overweight, hyperglycemia and tobacco use are modifiable risk factors for onset of retinopathy 9 and 17 years after the diagnosis of diabetes \u2013 A retrospective observational nation-wide cohort study"],"prefix":"10.1016","volume":"133","author":[{"given":"M.","family":"Tyrberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Nystr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.J.","family":"Arnqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bolinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Gudbj\u00f6rnsdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Landin-Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.W.","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.K.","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2017.08.009_b0005","doi-asserted-by":"crossref","unstructured":"Klein R, Klein BE. Are individuals with diabetes seeing better?: a long-term epidemiological perspective. Diabetes 59(8): 1853\u20131860.","DOI":"10.2337\/db09-1904"},{"issue":"4","key":"10.1016\/j.diabres.2017.08.009_b0010","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.2337\/diacare.26.4.1258","article-title":"Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes","volume":"26","author":"Hovind","year":"2003","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.diabres.2017.08.009_b0015","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/aje\/kwj166","article-title":"Lower-than-expected prevalence and severity of retinopathy in an incident cohort followed during the first 4\u201314 years of type 1 diabetes: the Wisconsin Diabetes Registry Study","volume":"164","author":"Lecaire","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.diabres.2017.08.009_b0020","doi-asserted-by":"crossref","unstructured":"Chew EY, et al. Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med 363(3): 233\u2013244.","DOI":"10.1056\/NEJMoa1001288"},{"issue":"1","key":"10.1016\/j.diabres.2017.08.009_b0025","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1056\/NEJMoa0808400","article-title":"Renal and retinal effects of enalapril and losartan in type 1 diabetes","volume":"361","author":"Mauer","year":"2009","journal-title":"N Engl J Med"},{"issue":"9647","key":"10.1016\/j.diabres.2017.08.009_b0030","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(08)61411-7","article-title":"Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial","volume":"372","author":"Sjolie","year":"2008","journal-title":"Lancet"},{"issue":"9647","key":"10.1016\/j.diabres.2017.08.009_b0035","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/S0140-6736(08)61412-9","article-title":"Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials","volume":"372","author":"Chaturvedi","year":"2008","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.diabres.2017.08.009_b0040","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.diabres.2006.04.002","article-title":"Temporal trends in the age-specific prevalence of diabetes and diabetic retinopathy in older persons: population-based survey findings","volume":"74","author":"Cugati","year":"2006","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"10.1016\/j.diabres.2017.08.009_b0045","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s11892-012-0283-6","article-title":"Current epidemiology of diabetic retinopathy and diabetic macular edema","volume":"12","author":"Ding","year":"2012","journal-title":"Curr Diab Rep"},{"issue":"9735","key":"10.1016\/j.diabres.2017.08.009_b0050","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","article-title":"Diabetic retinopathy","volume":"376","author":"Cheung","year":"2010","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.diabres.2017.08.009_b0055","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.diabres.2017.08.009_b0060","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.0954-6820.1986.tb02793.x","article-title":"Epidemiology of diabetes mellitus in Sweden. Results of the first year of a prospective study in the population age group 15\u201334 years","volume":"220","author":"Ostman","year":"1986","journal-title":"Acta Med Scand"},{"issue":"2","key":"10.1016\/j.diabres.2017.08.009_b0065","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2337\/diacare.26.2.349","article-title":"The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS)","volume":"26","author":"Henricsson","year":"2003","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.diabres.2017.08.009_b0070","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.2337\/diacare.26.10.2903","article-title":"Signs of nephropathy may occur early in young adults with diabetes despite modern diabetes management: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS)","volume":"26","author":"Svensson","year":"2003","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.diabres.2017.08.009_b0075","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jdiacomp.2006.01.002","article-title":"Early changes in glomerular size selectivity in young adults with type 1 diabetes and retinopathy. Results from the Diabetes Incidence Study in Sweden","volume":"21","author":"Torffvit","year":"2007","journal-title":"J Diabetes Complications"},{"issue":"2","key":"10.1016\/j.diabres.2017.08.009_b0080","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/dmrr.2574","article-title":"The risk for diabetic nephropathy is low in young adults in a 17-year follow-up from the Diabetes Incidence Study in Sweden (DISS). Older age and higher BMI at diabetes onset can be important risk factors","volume":"31","author":"Svensson","year":"2015","journal-title":"Diabetes Metab Res Rev"},{"issue":"6719","key":"10.1016\/j.diabres.2017.08.009_b0085","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/bmj.300.6719.230","article-title":"Analysis of serial measurements in medical research","volume":"300","author":"Matthews","year":"1990","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.diabres.2017.08.009_b0090","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3109\/00365518609083711","article-title":"A simplified enzyme-linked immunosorbent assay for urinary albumin","volume":"46","author":"Torffvit","year":"1986","journal-title":"Scand J Clin Lab Invest"},{"issue":"9","key":"10.1016\/j.diabres.2017.08.009_b0095","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0161-6420(86)33606-6","article-title":"An alternative method of grading diabetic retinopathy","volume":"93","author":"Klein","year":"1986","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.diabres.2017.08.009_b0100","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/archopht.1989.01070010243030","article-title":"The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years","volume":"107","author":"Klein","year":"1989","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.diabres.2017.08.009_b0105","unstructured":"Diabetic retinopathy study. Report Number 6. Design, methods, and baseline results. Report Number 7. A modification of the Airlie House classification of diabetic retinopathy. Prepared by the Diabetic Retinopathy. Invest Ophthalmol Vis Sci 1981;21(1 Pt 2): 1\u2013226."},{"key":"10.1016\/j.diabres.2017.08.009_b0110","doi-asserted-by":"crossref","unstructured":"Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7. Ophthalmology 1991;98(5 Suppl): 741\u2013756.","DOI":"10.1016\/S0161-6420(13)38009-9"},{"issue":"4","key":"10.1016\/j.diabres.2017.08.009_b0115","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/archopht.1984.01040030398010","article-title":"The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years","volume":"102","author":"Klein","year":"1984","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.diabres.2017.08.009_b0120","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2337\/dc11-1489","article-title":"Infant and toddler type 1 diabetes: complications after 20 years' duration","volume":"35","author":"Salardi","year":"2012","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.diabres.2017.08.009_b0125","doi-asserted-by":"crossref","first-page":"e0132492","DOI":"10.1371\/journal.pone.0132492","article-title":"Risk factors for retinopathy and DME in type 2 diabetes-results from the German\/Austrian DPV database","volume":"10","author":"Hammes","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.diabres.2017.08.009_b0130","doi-asserted-by":"crossref","unstructured":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329(14): 977\u2013986.","DOI":"10.1056\/NEJM199309303291401"},{"issue":"2","key":"10.1016\/j.diabres.2017.08.009_b0135","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2337\/db14-0930","article-title":"Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT\/EDIC","volume":"64","author":"Lachin","year":"2015","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.diabres.2017.08.009_b0140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2337\/dc13-2251","article-title":"Diabetic retinopathy and other ocular findings in the diabetes control and complications trial\/epidemiology of diabetes interventions and complications study","volume":"37","author":"Aiello","year":"2014","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.diabres.2017.08.009_b0145","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s001250051594","article-title":"UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis","volume":"44","author":"Stratton","year":"2001","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.diabres.2017.08.009_b0150","doi-asserted-by":"crossref","first-page":"308","DOI":"10.2337\/dc14-1203","article-title":"Impact of HbA1c, followed from onset of type 1 diabetes, on the development of severe retinopathy and nephropathy: the VISS Study (Vascular Diabetic Complications in Southeast Sweden)","volume":"38","author":"Nordwall","year":"2015","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1016\/j.diabres.2017.08.009_b0155","first-page":"S60","article-title":"Cardiovascular disease and risk management","volume":"39","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2017.08.009_b0160","doi-asserted-by":"crossref","unstructured":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998;317(7160): 703\u2013713.","DOI":"10.1136\/bmj.317.7160.703"},{"issue":"7","key":"10.1016\/j.diabres.2017.08.009_b0165","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.2337\/diacare.24.7.1275","article-title":"Risk of developing retinopathy in diabetes control and complications trial type 1 diabetic patients with good or poor metabolic control","volume":"24","author":"Zhang","year":"2001","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.diabres.2017.08.009_b0170","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.2337\/diacare.25.8.1320","article-title":"Blood pressure, lipids, and obesity are associated with retinopathy: the hoorn study","volume":"25","author":"van Leiden","year":"2002","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.diabres.2017.08.009_b0175","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0161-6420(02)01074-6","article-title":"The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes : the atherosclerosis risk in communities study","volume":"109","author":"Klein","year":"2002","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.diabres.2017.08.009_b0180","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/jama.2010.1111","article-title":"Prevalence of diabetic retinopathy in the United States, 2005\u20132008","volume":"304","author":"Zhang","year":"2010","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.diabres.2017.08.009_b0185","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.ophtha.2006.10.023","article-title":"Biologic risk factors associated with diabetic retinopathy: the Los Angeles Latino Eye Study","volume":"114","author":"Varma","year":"2007","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.diabres.2017.08.009_b0190","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/OPX.0000000000000255","article-title":"Differences in neuroretinal function between adult males and females","volume":"91","author":"Ozawa","year":"2014","journal-title":"Optom Vis Sci"},{"issue":"2","key":"10.1016\/j.diabres.2017.08.009_b0195","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3109\/02713683.2014.958500","article-title":"Male-female differences in diabetic retinopathy?","volume":"40","author":"Ozawa","year":"2015","journal-title":"Curr Eye Res"},{"issue":"Suppl 2","key":"10.1016\/j.diabres.2017.08.009_b0200","doi-asserted-by":"crossref","first-page":"S253","DOI":"10.1016\/S0039-6257(02)00387-9","article-title":"Diabetic retinopathy: more than meets the eye","volume":"47","author":"Gardner","year":"2002","journal-title":"Surv Ophthalmol"},{"issue":"9","key":"10.1016\/j.diabres.2017.08.009_b0205","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.2337\/db05-1635","article-title":"Diabetic retinopathy: seeing beyond glucose-induced microvascular disease","volume":"55","author":"Antonetti","year":"2006","journal-title":"Diabetes"},{"issue":"2\u20133","key":"10.1016\/j.diabres.2017.08.009_b0210","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10633-005-4187-5","article-title":"Multifocal electroretinography (mfERG) in insulin dependent diabetics with and without clinically apparent retinopathy","volume":"110","author":"Tyrberg","year":"2005","journal-title":"Doc Ophthalmol"},{"issue":"3","key":"10.1016\/j.diabres.2017.08.009_b0215","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10633-011-9298-6","article-title":"Electrophysiological studies in newly onset type 2 diabetes without visible vascular retinopathy","volume":"123","author":"Tyrberg","year":"2011","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.diabres.2017.08.009_b0220","doi-asserted-by":"crossref","unstructured":"Harrison WW, et al. Multifocal Electroretinograms Predict Onset of Diabetic Retinopathy in Adult Patients with Diabetes. Invest Ophthalmol Vis Sci 2011;9:52(2):772\u2013777.","DOI":"10.1167\/iovs.10-5931"},{"key":"10.1016\/j.diabres.2017.08.009_b0225","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.steroids.2015.08.002","article-title":"The estrogenic retina: the potential contribution to healthy aging and age-related neurodegenerative diseases of the retina, in Steroidogenesis: the Classics and Beyond","volume":"103","author":"Cascio","year":"2015","journal-title":"Steroids"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822717305272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822717305272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T12:15:01Z","timestamp":1656245701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822717305272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":45,"alternative-id":["S0168822717305272"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2017.08.009","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overweight, hyperglycemia and tobacco use are modifiable risk factors for onset of retinopathy 9 and 17years after the diagnosis of diabetes \u2013 A retrospective observational nation-wide cohort study","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2017.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}